Adaptyv GTM brain

Adaptyv provides automated protein validation experiments and data to biotechnology, pharmaceutical and computational protein design teams.

category

Automated protein validation

market profile

  • text: AI protein design teams need experimental data to determine whether candidate proteins behave as predicted.
  • text: Protein foundries and outsourced labs compete to provide data for iterative design workflows, with different assay and service scopes.

personas

  • title: Head of protein engineering
    pains:
    • Experimental throughput and turnaround limit how quickly the team can evaluate candidate designs.
    • Needs reproducible data across successive design rounds.
  • title: Computational protein design scientist
    pains:
    • Predicted candidates need real experimental measurements before the team can prioritize them.
    • Disconnected data packages make comparison across design rounds cumbersome.
  • title: Biotech R&D program lead
    pains:
    • Coordinating external assay quotes and schedules creates uncertainty.
    • Needs clear cost, turnaround and assay fit to plan the next milestone.

icp

  • text: Biotech and pharmaceutical R&D teams developing therapeutic proteins or engineered enzymes and outsourcing characterization.
  • text: AI-first protein design organizations generating batches of candidates that require repeated experimental validation and machine-readable data.
  • text: Academic or research groups participating in protein design competitions and testing computational designs.

message pillars

  • text: Shorten the time between sequence design and experimental results, subject to service availability.
  • text: Use automation to deliver consistent experimental results.
  • text: Manage ordering and analysis in one platform.

objections

  • objection: Will your assays work for our design and target?
    response: Discuss sample compatibility, assay choice and acceptance criteria with the scientific team before committing a batch.
  • objection: Does binding data prove a therapy will work?
    response: No. Binding is an early experimental result; functional, safety and subsequent studies are separate questions.
  • objection: What will this cost and how fast is it?
    response: Configure the batch and confirm assay options and turnaround; the faster Prime offering is described as private beta.

competitors

  • name: Twist Bioscience
    why: Provided outside validation of protein designs alongside Adaptyv in a reported project.
  • name: Ginkgo Bioworks
    why: Offers automated biological engineering and foundry services with partial overlap.
  • name: Arzeda
    why: Provides protein and enzyme engineering services, overlapping on some customer programs.

influencers

  • name: Julian Englert
    url: https://www.nasdaq.com/press-release/adaptyv-bio-creates-a-new-paradigm-for-protein-engineering-using-generative-ai-open
    why: Co-founder and CEO discusses protein engineering and company strategy.

keywords

  • protein engineering assays
  • protein binding validation
  • automated protein foundry
  • AI protein design validation
  • protein expression screening
  • high throughput protein characterization
  • protein assay API

voice

  • scientific and data-driven
  • fast and ambitious
  • developer-friendly

signals

  • text: An AI biology team is generating protein candidates faster than it can obtain experimental feedback.
  • text: A biotech launches a protein engineering program requiring repeat characterization and structured data.

stack

  • API

hiring

  • Lab Automation Engineer
  • Scientist, Binding Kinetics
  • Scientific Account Executive
  • Head of Software Engineering

pricing

model: usage
starting price: From $149 per protein for the displayed standard configuration with two replicates

motion

hybrid

channels

  • scientific sales
  • website
  • blog
  • X
  • protein design competitions
  • API partnerships

confidence

high

Founders

  • name: Julian Englert
    title: Founder
    role: Founder
    bio: Protein Data Dealer @ Adaptyv
  • name: Daniel Nakhaee-Zadeh Gutierrez
    title: Founder
    role: Founder
    bio: I am passionate about engineering biology to positively impact society and the environment. I have been lucky enough to develop my experience over the years in the fields of immunoengineering, synthetic biology and computational biology in some of the best universities in the world (Harvard, University of Leeds, KAIST, EPFL). Now in charge of Operations at Adaptyv.

Back to YC companies